TOKYO (Reuters) - Pfizer Inc. and Astellas Pharma Inc. have received marketing approval from Japan’s health ministry for the arthritis treatment Celecox in Japan, the companies said on Friday.
Celecox, first launched in the United States in 1999 and marketed as Celebrex or Celebra, is a non-steroidal anti-inflammatory drug used to relieve the inflammation and pain […]
Product: AspirSpray topical pain reliever, 3 fluid ounces, $29.95.
• Key ingredients: Trolamine salicylate, aloe vera, glycerin and isopropyl alcohol.
• The pitch: Fast relief for back, neck, hand, foot, joint and minor arthritis pain, muscle aches, shin splints, tendinitis, carpal tunnel, sunburn and bug bites.
• How it works: Trolamine salicylate is an analgesic that inhibits contractions […]
WASHINGTON, DC, United States (UPI) — Pfizer`s 2006 fourth-quarter earnings slightly beat Wall Street`s expectations, but at the same time the company said it was cutting 10,000 employees and making several other changes to save up to $2 billion.
‘We are facing significant challenges,’ said Jeffrey Kindler, Pfizer`s chairman and chief executive officer, in announcing the […]